Katie Coleman, MSPH, is the owner and principal at Research to Practice, LLC, where she leverages extensive applied experience working with a diverse range of publi ...
Proposed changes to the 2020 federal Transparency in Coverage rule could significantly improve researchers’ and other data users’ ability to access and analyze price data.
Engagement-maximizing architectures such as infinite scroll, autoplay, and emotionally targeted notifications remain broadly permissible. That gap, however, is now being challenged on multiple fronts.
The Quality Improvement Organization framework offers a novel opportunity: a preexisting federal authority that states can ...
James F. Blumstein is the University Distinguished Professor of Constitutional Law and Health Law and Policy at Vanderbilt University Law School and Medical School. He is also the director of the ...
The history of HCBS demonstrates that its growth is not, in fact, evidence of massive undetected fraud, but rather is based on decades of federal policy response to major demographic change, guided by ...
US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.
Medicaid, offers a timely model for how states can expand access to home- and community-based services for middle-income ...
Health Affairs' Jeff Byers welcomes Deputy Editor Leslie Erdelack back to the pod to break down recent turbulence at the FDA following the departure of Vinay Prasad, whose decisions around ...
Judith Auerbach. Judith D. Auerbach, PhD, is Professor, Division of Prevention Science, School of Medicine at the University of California, San Francisco. Trained as a sociologist ...
To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled ...
Dana M. Johnson, PhD, is a Health Disparities Research Scholars Postdoctoral Fellow at the University of Wisconsin-Madison School of Medicine and Public Health.